<code id='6D8EB44237'></code><style id='6D8EB44237'></style>
    • <acronym id='6D8EB44237'></acronym>
      <center id='6D8EB44237'><center id='6D8EB44237'><tfoot id='6D8EB44237'></tfoot></center><abbr id='6D8EB44237'><dir id='6D8EB44237'><tfoot id='6D8EB44237'></tfoot><noframes id='6D8EB44237'>

    • <optgroup id='6D8EB44237'><strike id='6D8EB44237'><sup id='6D8EB44237'></sup></strike><code id='6D8EB44237'></code></optgroup>
        1. <b id='6D8EB44237'><label id='6D8EB44237'><select id='6D8EB44237'><dt id='6D8EB44237'><span id='6D8EB44237'></span></dt></select></label></b><u id='6D8EB44237'></u>
          <i id='6D8EB44237'><strike id='6D8EB44237'><tt id='6D8EB44237'><pre id='6D8EB44237'></pre></tt></strike></i>

          explore

          explore

          author:comprehensive    Page View:257
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          Novartis develops a rapidly manufactured CAR
          Novartis develops a rapidly manufactured CAR

          RubyWallauforSTATNEWORLEANS—Forsomepatientssufferingwithcertainbloodcancers,CAR-Ttherapycanofferthet

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          How a key Senate committee is planning to regulate PBMs

          DraftlegislationauthoredbySenateFinanceChairRonWyden(D-Ore.)andrankingmemberMikeCrapo(R-Idaho)includ